Eat triglycerides

Dietary fats, from olive oil to cocoa butter to beef tallow, are made of triglycerides.

Triglycerides are simply three ("tri-") fatty acids attached to a glycerol backbone. Glycerol is a simple 3-carbon molecule that readily binds fatty acids. Fatty acids, of course, can be saturated, polyunsaturated, and monounsaturated.

Once ingested, the action of the pancreatic enzyme, pancreatic lipase, along with bile acids secreted by the gallbladder, remove triglycerides from glycerol. Triglycerides pass through the intestinal wall and are "repackaged" into large complex triglyceride-rich (about 90% triglycerides) molecules called chylomicrons, which then pass into the lymphatic system, then to the bloodstream. The liver takes up chylomicrons, removes triglycerides which are then repackaged into triglyceride-rich very low-density lipoproteins (VLDL).

So eating triglycerides increases blood levels of triglycerides, repackaged as chylomicrons and VLDL.

Many physicians are frightened of dietary triglycerides, i.e, fats, for fear it will increase blood levels of triglycerides. It's true: Consuming triglycerides does indeed increase blood levels of triglycerides--but only a little bit. Following a fat-rich meal of, say, a 3-egg omelet with 2 tablespoons of olive oil and 2 oz whole milk mozzarella cheese (total 55 grams triglycerides), blood triglycerides will increase modestly. A typical response would be an increase from 60 mg/dl to 80 mg/dl--an increase, but quite small.

Counterintuitively, it's the foods that convert to triglycerides in the liver that send triglycerides up, not 20 mg/dl, but 200, 400, or 1000 mg/dl or more. What foods convert to triglycerides in the liver? Carbohydrates.

After swallowing a piece of multigrain bread, for instance, carbohydrates are released by salivary and gastric amylase, yielding glucose molecules. Glucose is rapidly absorbed through the intestinal tract and into the liver. The liver is magnificently efficient at storing carbohydrate calories by converting them to the body's principal currency of energy, triglycerides, via the process of de novo lipogenesis, the alchemy of converting glucose into triglycerides for storage. The effect is not immediate; it may require many hours for the liver to do its thing, increasing blood triglycerides many hours after the carbohydrate meal.

This explains why people who follow low-fat diets typically have high triglyceride levels--despite limited ingestion of triglycerides. When I cut my calories from fat to 10% or less--a very strict low-fat diet--my triglycerides are 350 mg/dl. When I slash my carbohydrates to 40-50 grams per day but ingest unlimited triglycerides like olive oil, raw nuts, whole milk cheese, fish oil and fish, etc., my triglycerides are 50 mg/dl.

Don't be afraid of triglycerides. But be very careful with the foods that convert to triglycerides: carbohydrates.

 

 

 

 

 

 

 

Comments (31) -

  • Kurt

    6/8/2011 2:51:47 AM |

    There must be genetic variations, though, as my triglycerides have measured between 78 and 90 on every test since 1993. For the past two years, I've been eating a 20% fat diet (with about 50% carbs), and on my latest VAP test, my triglycerides were 78. The diet, by the way, lowered my LDL 30%.

  • Ian Goldsmid

    6/8/2011 2:55:47 AM |

    Dr. Davis

    Could you please clarify:

    If I have one slice of gluten free mixed grain /seed toast - and very liberally heap Organic Coconut Oil & Almond Butter on it - am I still going to get the exaggerated carbohydrate to triglyceride conversion effect from the toast?

    Thanks, IJG

  • Gene K

    6/8/2011 3:28:45 AM |

    Dr Davis,

    How much TG-rich foods is it safe for APOE 4 people to consume? Will this amount depend on their fasting TG? Will it be per meal or a day's total?

    Thank you.

  • Markus Damian

    6/8/2011 7:16:16 AM |

    I think this article is excatly on target- I ate a low-fat, high-carb vegetarian diet for years, and at one point my measured triglyceride levels were > 300. After I started omitting most refined carbs from my diet (and upping my fat/protein intake correspondingly), my last reading has been 88. So, for me at least, dietary intake of triglycerides is not substantially related to blood levels.

  • Markus D

    6/8/2011 7:32:02 AM |

    ... having said that, there is something which I don't quite understand. Given that virtually the entire human population is on a high-carb feast, it must be that some of us react differently to high-carb diet than others, otherwise everyone would have elevated triglyc levels, right? My mother, who is certainly genetically quite close to me, eats a high-carb, low-fat diet, and her triglyceride levels are normal ...  Many thanks, M.

  • Might-o'chondri-AL

    6/9/2011 12:18:07 AM |

    EPA (eicosa-pentaenoic fatty acid)  an omega-3  poly-unsaturated fatty acid reduces the amount of glucose that is made into tri-glycerides ("trigs") , thus decreasing de-novo lipo-genesis put out by the liver.  When I added daily concentrated fish oil  with 1,500 mg EPA & 750 mg DHA to my moderate carb diet my NMR  tested measurement of trigs went from 90 mg/dL down to 42 mg trigs/dL (tests  were 4 months apart).  

    EPA also increases the amount of insulin related glucose transporters inside skeletal muscle cells, which allays insulin resistance;  it (EPA) induces the skeletal muscles to "burn" more glucose for ATP energy  in oxidative phosphorylation , which decreases irritating lactate output that contributes to body "aches".  Insulin in circulation can then also work as a co-fact0r with EPA,  together they go on to increase functional  leptin  levels  (leptin = anti-appetite);  thus  we get less impulse to "graze"   between meals on  carbs that make  trigs.

  • carb sane

    6/9/2011 11:57:11 AM |

    Actually, it has been established that DNL is NOT a major source of fatty acids in VLDL.

    http://carbsanity.blogspot.com/2011/05/where-do-triglycerides-come-from-part-i.html

  • majkinetor

    6/9/2011 1:49:40 PM |

    Actually, its around 20%

    http://ajpendo.physiology.org/content/286/4/E577.full

  • majkinetor

    6/9/2011 1:49:59 PM |

    Nice. I didn't know that. Thats pretty big amount of EPA/DHA, it is therapeutic amount often used for COX-2 inhibition.

    Can you tell more about the dosage ? Did you try smaller dose ? Is it fish oil or fish capsule or simply fish ? What are you thoughts about potential problems with PUFA and oxidation in regard to fish oil ?

  • carb sane

    6/9/2011 5:05:24 PM |

    Firstly, that's not about VLDL.  Secondly, that means around 80% comes from dietary fat.    Did you read my link?

  • Might-0'chondri-AL

    6/9/2011 6:15:27 PM |

    Hi majkinetor,
    I only went from no fish oil supplementation as an experiment to taking 1 tsp of Natural Factor's "pharmaceutical grade"  (  concentrated Canadian product's total fish oil=4,400 mg.  with 2,630 Omega 3 fatty acids of which 1,500 = EPA & 750 = DHA)  taken, as free  poured liquid along with morning food and evening food in 1/2 tsp measuring spoon slurps. Intake  of liquid oil was at the same time ate carbs , and carb intake was similar for when had 1st measured trigs when wasn't supplementing with fish oil  .  

    I personally don't think PUFA oxidation is an issue in diets that have lots of substrate for gut bacteria to make short chain 4 carbon fatty acid butyrate. It (butyrate) up-regulates many distinct  GST (glutathione S-transferase) genes;  these go on to tackle multiple lipid peroxidation by-products  (ex:  activity neutralizes 4-hydroxy- nonenal &  trans-alk-enals/dienals ),  while  micro-somal GST promotes the glutathione conjugation to electro-philes  which then can act to decrease lipid hydro-peroxide activity.

  • majkinetor

    6/10/2011 7:25:50 AM |

    Ah, sorry, I missread your post.

  • majkinetor

    6/10/2011 7:30:08 AM |

    Secondly, that means around 80% comes from dietary fat
    Not at all.
    80% from dietary fat AND cho.

  • Jimmy

    6/10/2011 11:11:24 AM |

    Might: Do you live in Canada?
    Jim

  • Helen

    6/10/2011 11:25:24 AM |

    M-Al,

    I used to take fish oil, but now that I'm measuring my glucose daily, I find that even a small dose immediately raises my fasting glucose 10-15mg, and somewhat worsens my post-prandial readings.  My own observation is in keeping a study that showed that prediabetic women's glucose control was worsened by a fish oil supplement.  (I don't have the link handy.)  Can you explain?

    I have the same troubles with modest supplements of vitamin C and niacin, though I'm sure for different reasons.  I find it interesting, and I don't mean that in any coded way, that two of Dr. Davis' recommended supplements  (fish oil and niacin) impair glucose control in me and in some studies.  I am wondering if this might explain in part his advice to shun carbs.  In the context of those supplements, carbs are not well tolerated.

  • Dr. William Davis

    6/10/2011 12:12:00 PM |

    Several commenters make the point that there is genetic variation in susceptibility to triglyceride intake and carbohydrate intake.

    Absolutely. Two people on the same diet can have wildly different results. Part of this is attributable to apo E genotype, apo C genotype, lipoprotein lipase and hepatic lipase genotypes, among others. Body weight and previous eating habits will also enter the equation. However, in most people increased triglyceride intake does not result in substantial increase in serum triglycerides.

  • Might-o'chondri-AL

    6/10/2011 9:59:19 PM |

    Hi Helen,
    I've heard some respond as you mention;  I wonder if they were all overweight during the data collection period, as pre-diabetic could imply.  In your circumstances (ie: blood glucose goes up with supplements)  it would be instructive to know if  you've a tendency for excess weight.

    My own niacin use went from none to 3x per day of 500 mg.  niacin taken with meals;   my own 2011 NMR lipid tests done 4 months apart were as follows.  Without any niacin fasting NMR cholesterol test results:  LDL = 139,  HDL=45,  total number of LDL particles  = 1,676,  with the number of small LDL particles  = 1,021 nmol/dL .  As for NMR cholesterol test with 1,500 mg daily total  niacin :  LDL = 100, HDL = 64,  total number of LDL particles = 976 , with the number of small LDL particles = nmol/dL.

    The nice plunge in small LDL doesn't seem to be due to a massive restriction of carbs;  in fact,  both my  HbA1c  and fasting serum glucose test result ciphers  went up slightly after I had  instituted niacin &  EPA/DHA fish oil  (started both at same time).   Incidentally,  I've never had  weight gain problems  and unintentionally lost 10 pounds I didn't intend to  since started taking the fish oil;  losing so much small LDL was more than thought possible and maybe wasn't 100% due to the niacin  (also daily  added  6,000 IU vitamin D3 from none, taken as 2,000 IU  with each meal).

    So,  before you decide that niacin & EPA/DHA supplements driving up your post-prandial glucose is positively detrimental it might be good to have your own baseline data (ie:  NMR for cholesterol & HbA1c for accretion of  blood sugar) .  If you are in the USA you can get a valid blood draw order in ANY state at all and the emailed results by using  cheapest online arrangement from summitcountymedicalsociety.prepaidlab.com ;  their doctor orders the blood test for you and,  of course, I have no financial interest in this .

  • Might-o'chondri-AL

    6/10/2011 10:04:42 PM |

    edit,
    see 2nd paragraph's last sentence to Helen above, missing number in last set of data is for number of small LDL nmol/dL and should be 96 (ninety-six) ... in other words  that data shows that with niacin the  small LDL  "plunged" to 96 from being 1,021 nmol/dL without niacin supplementation.

  • Helen

    6/11/2011 5:27:07 AM |

    Hi M-Al,

    I'm different from a lot of visitors to this blog in that I have never had cholesterol problems.  I don't remember my exact numbers but my HDL and LDL split has been deemed "ideal," and my triglycerides range from 44-48, with total cholesterol being about 157.  

    My current BMI is 20 or less (haven't checked the charts lately) and my highest ever was 25, about a year ago.  Generally, I've been in the 23 range.  So, no, I don't have a propensity to weight gain.  On the other hand, I'm borderline diabetic.  Last year, at my highest BMI, my A1C was 6.4.  On low-carb, it slowly got down to 6.0, and my last test, on low-fat, was also 6.0, although according to my meter readings, taken at least three times a day, it should be 5.3.  I'm definitely right on the border with the diabetes, though have pushed it back some over the past year.  My blood sugar *sometimes* shoots to 200 or over within the first hour of eating (a "diabetic" number, though my endocrinologist says it has to be 200 at two hours to be considered clinical diabetes), but it quickly goes down again.  My liver seems to pump out a lot of glucose.  I tend to have a fasting glucose between 109 and 125.  Sometimes it gets as low as 99.  On low-carb, it ranged from 125 to 145, and was 160 a few times.  

    Needless to say, my biggest concern is my glucose level.  Metformin didn't help, low-carb didn't help much (and definitely made my tolerance for any amount of carbs next to zero - I once went to 198 on a carrot and half an orange, but I don't anymore.  It also gave me heart palpitations, worsened my insomnia, and greatly impaired my exercise tolerance), and I wonder if I'm just stuck with what I've got at this point.  Not that I'm throwing in the towel.  Fortunately, my cholesterol profile has  been ideal, my resting heart rate and blood pressure are low-normal, and my weight is okay without a struggle.  But I'm getting aches and pains in my joints and think the fish oil could help there.

  • Peter

    6/11/2011 1:32:44 PM |

    Dr. Davis, at one point you were concerned that you were eating too many nuts
    because your ratio of omega 3 and 6 was off.  What is your current thinking about the trade-offs?

  • Might-o'chondri-AL

    6/11/2011 10:02:26 PM |

    Hi Helen,
    lost 2 replies, says server error ... sorry

  • Might-o'chondri-AL

    6/11/2011 10:14:46 PM |

    Hmm Helen,
    Sounds like epigenetic or good old genetic polymorphism ... appears that Hexokinase II (HK II) is NOT staying inside skeletal muscle mitochondria and glucose-6-phosphate (G-6-P) is working to keep HK II in cell cytosol in a loop,  whereby HK II engenders glycogen output and instigates lots of G-6-P ... that cell has own glucose from glycogen so GLUT 4 (glucose transporters) move too far away to pick up blood glucose  ... liver glycogen  for it's part involves HK IV (glucokinase) and G-6-P too, but may not be root of  your syndrome ... too slow a rate of G-6-P degradation and /or too many carbon or nitrogen terminals on HK II would allow G-6-P to yank HK II  into metabolism cranking out glycogen ...  hey - twice wrote this already.

  • Might-o'chondri-AL

    6/12/2011 12:49:42 AM |

    Helen, Hi-
    Metaformin probably did not work for you because it functions to increase glucose uptake by provoking anaerobic glycolysis to create additional glucose demand;   you may already be doing plenty  of anaerobic glycolysis  as a consequence of your extra ordinary local glycogen synthesis.  The carbon from glucose with anaerobic glycolysis engenders a lot of lactate being produced; your aching joints and body pain syndrome fit the profile of excessive lactate in circulation.

    There is no easy way to determine what phase of the G-6-P dynamic with Hexokinase forms is not working normally, if even involved.  When we wean to real food our skeletal muscles start to run glucose metabolism with HK II and GLUT 4,  rather than the HK I and GLUT 1  we started with;  this change over occurs when we  starts to relatively "burn" both carbs and fats  and skeletal muscles develop  their insulin sensitivity.

    I am not  a clinician, and you have your personal physician to guide you; if I had a distorted  HK II  and G-6-P pattern ( that was unresponsive to low carbs)  I would try to end run it,  and not have skeletal muscle cells utilizing glucose to stop ratcheting up G-6-P and short out the negative feedback loop . I'd  significantly increase my consumption of  dietary fat in the explicit form of unheated virgin coconut oil  and fatty fish (for the EPA/DHA);  if taking EPA causes  blood sugar to rise it is probably because the EPA is driving skeletal muscles to "burn" fat , and thus skeletal muscles are using less of the HK II glycogen  which itself then used even less blood glucose as substrate  (ie: EPA  reduces blood glucose commonly used so glucose level in blood measures higher if cell metabolism aberrant  in the manner like I surmise).

  • Might-o'chondri-AL

    6/12/2011 4:28:39 AM |

    Hi Jim,
    Am not  residing in Canada.

  • majkinetor

    6/12/2011 7:04:12 AM |

    Vitamin C can give falsely higher values when measuring bunch of markers, most notably glucose. Its because it is so similar with glucose (very similar net formula, the same transporters in the body - GLUT, its made from glucose in animals etc...)

    About oil, it can only slow down carb absorption and let the body tolerate better. Did you experiment with other fish oil manufacturers ? Perhaps something in the product apart from fish oil makes you feel that way. For instance, ascorbyl palmitate is typical antioxidant used (along with Vitamin E) so this can be responsible for false higher reading.

  • majkinetor

    6/12/2011 7:22:27 AM |

    Helen, did you try megadosing with Vitamin C (~10g per day as frequent as you can). Vitamin C influences beta cells in the pancreas and deficiency is common in diabetes. Scorbutic guinea pigs show defects in insulin metabolism in vitro. Higher glucose levels compete with C for transporter. Add chromium if you didn't. Daily exercise will surely help. Since low carb made your glucose problem worst (most probable is higher hepatic insulin resistance that is consequence of low carb diet) you might try to return some safe starches back (for instance potato or rice) and keep CHO between 50 and 75 g per day.  Ashes and pains in the joint might be consequence of your too low carb diet since carbs are used for joint functions. Carbs are also used for intestinal mucus which so on very low carb you might have some micronutrient deficiencies.

  • Dee

    6/13/2011 7:47:05 PM |

    Have you tried adding D-ribose to your mix of supplements?  It has helped with my muscle aches from exercise.

  • Kris - Health Blog

    6/14/2011 7:52:50 AM |

    It seems that a lot of doctors would do well by going back a few years in time and re-reading Biochem 101.

  • Jim Anderson

    6/14/2011 7:05:22 PM |

    My wife and I have both been following a low-carb eating plan.  For me, that has meant increased fat consumption from the start.  I have felt full and satisfied after meals, and can go longer without feeling hungry.  I have also lost weight steadily.  My wife, however, has had a harder time of it.   She claims that is because women just have a harder time losing weight than men do.  That's true, I guess, in general, but I have also noticed that she seems to be avoiding fat a lot more than I do.  (Well, I don't avoid it at all!)  So she gets hungrier more often.  It is very difficult to overcome years and years of anti-dietary fat propaganda!

  • Joe Lindley

    6/30/2011 2:04:03 PM |

    Yes!  Thanks for the complete explanation of the fats vs. carbs impact.  I'm successfully on a low carb diet now after quitting Atkins years ago because my wife was worried I'd keep over from a heart attack.  With the right information out there now that dietary fat won't hurt you, people can stick to a low carb diet and get enough satiety (food satisfaction) with fats in the diet to stay on a diet.  It's truly been a disaster that the nutrition authorities shooed us away from dietary fats starting in the 1970s.  It's taken decades to get the word out that dietary fats are OK.  I published a nostalgic post on this about how Barney Fife got it right back in 1963:  http://bit.ly/m5eAhE

  • James Roberts

    7/30/2011 12:59:43 AM |

    Great post, great site.  I made my way to focusing on triglycerides by starting with Lipitor.  I had some bad though serious side effects (mostly insomnia),  so I dropped it and worked really hard on reducing fat intake.  That pretty much worked, but surprise (to me)... triglycerides went way up.  Now that I've also worked on cutting empty calories my levels are down to borderline.  Once you make it to a genuinely healthy diet everything seems to work out Wink
    cheers,
    James

Loading

Blood sugar lessons from a Type I diabetic

A friend of mine is a Type I, or childhood onset, diabetic. He's had it for nearly 50 years, since age 6. He's also in the health industry and is a good observer of detail.

He made the following interesting comments to me recently when talking about the effects of various foods on blood sugar:

"When I eat normally, like some vegetables or salad and meat, I dose up to 10 units of insulin to control my blood sugar.

"If I eat a turkey sandwich on two slices of whole wheat, I usually dose 15 units. The bread makes my blood sugar go to 300 if I don't.

"If I eat a Cousins's Sub [a local submarine sandwich chain], I dose 15 units. The bread really makes my blood sugar go up.

"I can only eat a Quarter Pound from McDonald's once a year, because it make my blood sugar go nuts. I dose 15-20 units before having it, and I feel like crap for two days afterwards.

"If I eat Mexican food, I have to dose 15-20 units. For some reason, it's gotten worse over the years, and I need to dose higher and higher.

"Chinese food is the absolute worst. I dose 20-25 units before eating Chinese. I'll often have to dose more afterwards, because my blood sugar goes so berserk."


Nothing beats the real-world observations on the impact of various foods on blood sugar than the observations of people with Type I diabetes. All the insulin they get is in a syringe. Dosing needs to match intake.

Personally, though I love the taste of Americanized Chinese food, I've always been suspicious of what exactly goes into these dishes. But I was unaware of the blood sugar implications.

The impact of Mexican I believe can be attributed to the cornstarch used in the tacos and tortillas, though I also wonder if there are other starches being snuck in, as well.

Lessons about omega-3s from Japan















Image courtesy of apc33.

Japan provides a useful "laboratory" for studying the effect of a culture that relies heavily on eating fish.

The JELIS Trial, the topic of a previous Heart Scan Blog post, showed that supplementation with the single omega-3 fatty acid, EPA, 1800 mg per day (the equivalent of 10 capsules of 'standard' fish oil that contains 180 mg per day of EPA, 120 mg of DHA) significantly reduced heart attack in a Japanese population. Interestingly, this benefit was additive to the already substantial intake of omega-3 fatty acids among the general Japanese population, a population with a fraction of the heart attacks found in western populations like the U.S. (approximately 3% over 5 years in Japanese compared to several-fold higher in a comparable American group).

While there may be genetic and other cultural and lifestyle reasons behind the dramatically reduced cardiovascular risk in Japanese, it is undeniably at least partially due to the increased intake of omega-3 fatty acids from fish. Incidentally, the purported benefits of omega-3 fatty acids provide a vigorous counter-argument to the idea that all humans should be vegetarians.

Anyway, if we were to take some lessons from the Japanese and their greater habitual intake of omega-3 fatty acids from fish, they might include:

--Rural and coastal Japanese are the sub-populations with the highest reliance on fish, about a quarter-pound a day. (Gives new meaning to the idea of a "Quarter Pounder," doesn't it?) This is at least five-times greater than the intake of an average American.

--Likewise, the blood level of omega-3s in the blood of Japanese is 5-fold higher than in Americans.

--The average intake of omega-3s (EPA + DHA) among a broadly-selected population of Japanese is 850 mg per day (320 mg EPA; 520 mg DHA). Intake ranges from 300 mg per day all the way up to 3100 mg per day.

--Greater omega-3 intake (EPA + DHA) is associated with lesser carotid intimal-medial thickness, an index of body-wide atherosclerosis.

--Japanese have far less heart attack and stroke despite greater prevalence of smoking (nearly half of Japanese) and drinking.

--Total fat intake (percent of calories) is nearly identical between Americans and Japanese. It's the proportion of fat calories from omega-3 that is greater, the proportion of omega-6 that is less in Japanese.


The Japanese eat their fish in ways that we do not: As sashimi (raw, as with sushi in its various forms like Nigiri and Chirashi); fried in tempura; shaved, dried fish sprinkled on about anything you can imagine (it's not as bad as it sounds); as a snack, as in dried cuttlefish (which you can purchase in packages as a portable, sweetened fish that you eat on-the-run--I know it sounds awful, but don't poke fun at it until you've tried it); in "soups" with soba noodles. Fish is commonly consumed with rice and soy sauce, as well as other soy-based foods, such as tofu, miso (soy bean paste), or natto. 


I believe that there are some lessons to take from the Japanese and their fish-consuming habits:

1) An omega-3 fatty acid intake of at least 1000 mg per day yields measurable cardiovascular benefits. 

2) Despite the fears over mercury and pesticide residues in fish, this seems to not have played out to be a real-life effect in the Japanese, who consume five-fold greater quantities of fish. 

3) My mother was right after all when she encouraged us to eat more fish. 


DIRECT Study result: Low-carb, Mediterranean diets win weight-loss battle

Drs. Iris Shai and colleagues released results of a new Israeli study, the Dietary Intervention Randomized Controlled Trial (DIRECT) Trial, that compared three different diet strategies. Of those tested, a low-carbohydrate diet was most successful at achieving weight loss.

You can find the full-text of the study on the New England Journal of Medicine website.

322 participants followed one of three diets over two year period. Compared head-to-head, the (mean) weight loss in each group was:

• 2.9 kg (6.4 lbs) for the low-fat group
• 4.4 kg (9.7 lbs) for the Mediterranean-diet group
• 4.7 kg (10.3 lbs) for the low-carbohydrate group

(Average age 52 years at start; average body-mass index, or BMI, 31.)

The conclusion was that the low-carb diet performed the best, with 60% greater weight loss, with the Mediterranean diet a close second.


The diets

The low-fat diet was based on the American Heart Association diet, with 30% of calories from fat (10% from saturated fat) and food choices weighted towards low-fat grains, vegetables, fruits, and legumes and limited additional fats, sweets, and high-fat snacks; calorie intake of 1500 kcal per day for women and 1800 kcal per day for men was encouraged.

The Mediterranean diet was a moderate-fat diet rich in vegetables, with reduced red meat, and poultry and fish replacing beef and lamb. Total calories from fat of 35% per day or less was the goal, with most fat calories from olive oil and a handful of nuts. Like the low-fat program, calories were limited to 1500 kcal per day for women, 1800 kcal per day for men.

The low-carbohydrate diet was patterned after the popular Atkins’ program, with 8% participants achieving the ketosis that Dr. Atkins’ advocated as evidence that a fat-burning metabolism was activated, rather than sugar-burning as fuel. For the 2-month “induction phase,” 20 grams of carbohydrates per day was set as the goal, followed by 120 grams per day once the weight goal was achieved. Unlike the other two diets, calories, protein and fat were unlimited.


Weight loss, lipids, inflammation

You can see from the weight loss graph that the low-carb approach exerted the most dramatic initial weight loss. Interestingly, much of the weight-loss benefit was lost as the carbohydrate intake increased, by study design, back to 120 mg per day. However, the other two diet approaches showed similar phenomena of “giving back” some of the initial weight loss.

The low-carbohydrate diet exerted the greatest change in cholesterol, or lipid, panels: increased HDL 8.4 mg/dl vs. 6.3 mg/dl on low-fat; the triglyceride response was the most dramatic, with a reduction of 23.7 mg/dl vs. 3.7 mg/dl on low-fat. Interestingly, the LDL cholesterol-reducing effect of all three diets was modest, with the most reduction achieved by the Mediteranean diet.

The inflammatory measure, C-reactive protein (CRP), was reduced most effectively by the low-carb and Mediterranean diets, least by the low-fat diet. HbA1c, a measure of long-term blood sugar, dropped significantly more on the low-carb diet.

When the final dietary composition was examined, interestingly, there really were only modest differences among the three diets, with 8% less calories from carbs, 8% greater calories from fat, comparing low-carb to low-fat, with Mediterranean intermediate.



Taken at face value, this useful exercise quite clearly shows that, from the perspective of weight loss and correction of metabolic parameters like triglycerides, HDL,CRP, and blood sugar, low-carbohydrate wins hands down, with Mediterranean diet a close second.

It also suggests that a return to a carbohydrate intake of 120 mg/day allows a partial return of initial weight lost, as well as deterioration of metabolic parameters after the initial positive changes.

Although the study has already received some criticism for such potential flaws as the modest number of Atkins’ followers achieving ketosis (8%), suggesting lax adherence, and the reintroduction of the 120 mg/day carbohydrate advice, I can suspect that these may have been compromises drawn to satisfy some Institutional Review Board. (Whenever a study is going to be conducted involving human subjects, a study needs to pass through the review of an Institutional Review Board, or IRB. IRB’s, while charged to protect human subjects from experimental abuses, also tend to be painfully conservative and will block a study or demand changes even if they are not dangerous, but just veer too far off the mainstream.)


However, several unanswered questions remain:

1) How would the diets have compared if the carbohydrate restriction were continued for a longer period, or even indefinitely? (The divergences would likely have been dramatic.)
2) Will low-carb exert the same cardiovascular event reduction that the Mediterranean approach has shown in the Lyon study and others?
3) Are there effects on health outside of the measures followed that differ among the three diets, such as cancer? (I doubt it, especially given the modest real differences over time. But this will be the objection raised by various "official" organizations.)


I would further propose that:

Low-fat diets are dead

The AHA will cling to their version of low-fat diet, based on difficulty in changing course for any large, consensus-driven organization, not to mention the substantial ($100’s of millions) revenues derived from endorsing low-fat manufactured products. The AHA will also point to the lack of difference in LDL cholesterol among the three, since they cannot get beyond the fact that there’s more to coronary risk—a lot more—than LDL.


Off-the-shelf diets achieve off-the-shelf results

If you just need a T-shirt, a medium might fit fine. But if you’d like a nicely fitting suit or dress, then tailoring to your individual proportions is needed. When aiming towards maximizing benefits on lipoproteins and coronary risk, none of these diets achieve the kinds of changes we often need for coronary plaque reversal, as in the Track Your Plaque program. That requires making dietary changes that exert maximal effects on lipoprotein patterns.

Do I sell heart scans?

I came across a criticism of the Track Your Plaque program recently that suggested that it was nothing more than a program to sell CT heart scans.

Huh?

I suppose if you say that the Track Your Plaque program is nothing more than a way to sell heart disease prevention, omega-3 fatty acids from fish oil, vitamin D, better nutrition, and better identification of causes of heart disease . . . well, I believe that would be true.

But is the program a "front" to sell heart scans?

No, it is not, nor has it ever been.

I've heard about these peculiar suspicions about the program before. Though I've never taken them seriously, let me clear up any lingering uncertainty:


--I have no relationship with any heart scan center, scanning facility, or hospital other than to interpret heart scans.

I do not own a scanner, I have no financial interest in a scanner or scanning center, nor have I ever had any interest. I also have no plans to do so in the future. Let business people in the imaging business do that. I want no part of it. I have seen what these people go through and, frankly, I want no part of it, nor do I want the appearance that I am advocating scans to make money. I'm accused of trying to make money from scans even when I do not have any financial interest!


--I do not sell heart scans or imaging packages, nor have I ever done so.

You can't buy a scan through Track Your Plaque, The Heart Scan Blog, or through me. To me, heart scans are simply a measuring tool to identify the extent of coronary plaque, as well as a tracking tool to follow its course. Without it, there would be no Track Your Plaque. But there is also no alternative. The closest alternative would be carotid intimal-medial thickness, a technique, while useful, is a distant second choice to indirectly gauge coronary plaque by examining the thickness of the carotid lining (not carotid plaque). Perhaps in 10 years, a better measure to gauge and track coronary plaque will emerge that has superior aspects over CT heart scanning. If reasonable, safe, accessible, and quantitative, then Track Your Plaque may adopt that technology as its measuring tool.

Track Your Plaque is not about heart scanning; Track Your Plaque is about measuring and tracking plaque that, in 2008, is still best accomplished with CT heart scans.


--I make loads of money from heart scans and Track Your Plaque.

Yeah, right.

Track Your Plaque is a volunteer venture for my team; none of us get paid a penny for doing all we do, including me. We charge a membership fee on the website (somewhere around $6-7 a month) to pay our expenses, such as code writing for our proprietary software (much of it remains under development), printing costs, modest legal costs, the costs of doing business (e.g., accountant). Despite the fact that Track Your Plaque and the Heart Scan Blog occupies a substantial part of the day of the Track Your Plaque team, none of us are reimbursed for our time. I do believe, however, that this concept is so enormously powerful that it will, someday, pay us all enough to allow us to devote more time and effort to it.

Personally, I can't wait to devote more time and effort to this concept that is simple, logical, and effective. More research is needed, more development is needed, more discussion is needed. Right now, it is all accomplished outside of our busy schedules, including my full-time cardiology practice. I continue to have 7 am procedures, middle-of-the-night calls, weekend hospital rounds and emergencies (though virtually none of these are the patients involved in prevention, but the "other" people: atrial fibrillation, elderly heart failure patients, rhythm disorders, cardiomyopathies, pulmonary hypertension, peripheral vascular disease, the non-compliant).


--The book, Track Your Plaque, is a gimmick to sell you a heart scan.

No, it's a program that relies on this technology. But there's no special deal, no discounts, no steering to heart scan centers that I have a special arrangement with. No such thing exists, nor has there ever been such an arrangement.


I've heard it all. Early on, when I was helping my friend, Steve Burlingame and his wife, Nancy, set up Milwaukee Heart Scan, I helped by providing medical oversite, education of physicians and public, and interpreting heart scans. After all, in the "early days," nobody knew anything about heart scans. It was a long, hard climb against ignorance, habit, entrenched thinking, stubbornness, and stupidity. I've been paid next to nothing for all this. I told Steve long ago that, given the extraordinary expenses of maintaining an independent scanning center, that he should first pay his expenses, pay his technologists, receptionists, and nurse, pay himself, then pay me for reading scans if he had any money left over. Most of the time, Steve had nothing left over and I was paid nothing.

So, while some of my colleagues were assuming that I was rolling in money from "promoting" heart scans, the reality was that I was doing nearly everything for free. (It certainly wasn't the high life I was living; I don't drive a Mercedes, take fancy vacations, none of that. In fact, I work about 51 weeks a year.)

Why do I do this if it doesn't yield a big flow of money? Because I believe in it as a superior path to the conventional. If I were simply interested in making more money--I wouldn't do it. I would simply do what all my cardiology colleagues are doing: more heart catheterizations, more angioplasties and stents, learning how to do carotid stents, iliac stents, peripheral angioplasty, renal stents, acquiring the skills to put in defibrillators, new device insertion like umbrellas in the interatrial septum, etc. There's plenty more money in that. It's also not that hard. I know, because that is my background: high-risk cardiac interventions. That's what I was trained to do, that's what I did from a number years, until I started to see that this was nothing more than "putting out fires" in people who became increasingly ill and reliant on bail-out procedures. It makes lots of money, but it is also fundamentally wrong.

So, no, I do not sell heart scans, nor is the Track Your Plaque program or The Heart Scan Blog meant to promote heart scans except as a tool for tracking this disease.

That's it, pure and simple.

Plaque is the new cholesterol

Which is more important: cholesterol or coronary plaque?

Ask what Dr. Michael Eades' calls "statinators," and you will likely receive a befuddled look. Or, you might receive comments like "Measuring plaque has never been shown to reduce mortality."

While risk factors for heart disease are important, no doubt (my office practice is about half lipid consultation and complex hyperlipidemia management), for many they have become an end in themselves. In other words, LDL cholesterol in particular dominates thinking so much that it has caused many to exclude the fact that plaque---coronary atherosclerotic plaque---is the disease itself.

Dozens of studies, from the St. Francis Heart Study to the 25,000-participant UCLA registry, to the recently-released MESA database (ethic differences, women, as well as superiority to carotid measures) have repeatedly shown that heart scan scores (coronary artery calcium scores) are superior to conventional risk factors (usually via the Framingham risk score) for predicting future heart attack and other events. And the differences are not minor incremental differences. The predictive power of plaque measurement via heart scanning is multiples better: 4 times, 10 times, 20 times or more in various subgroups.

Much of what we do in medicine is not based on long-term studies of outcome, pitting some diagnostic measure or treatment against placebo. It is already standard practice to measure plaque via heart catheterization, crudely via stress testing, and increasingly popular CT coronary angiography. None of these methods have been subjected to studies comparing testing vs. not testing in a large population, followed by some program of prevention to assess differences in mortality, heart attack, and other events.

Why should heart scan be held to such a standard?

Dr. Scott Grundy, lipid guru and one of the experts who sat on the Adult Treatment Panel-II for lipid management guidelines, recently stated [emphasis added]:

"Imaging has at least 3 virtues. It individualizes risk assessment beyond use of age, which is a less reliable surrogate for atherosclerosis burden; it provides an integrated assessment of the lifetime exposure to risk factors; and it identifies individuals who are susceptible to developing atherosclerosis beyond established risk factors. Also of importance, in the absence of detectable atherosclerosis, short-term risk appears to be very low."

Well said, and from a vocal statinator, to boot.

Sadly, Dr. Grundy goes on to say how plaque imaging can serve to better determine who will benefit from statin drug use.

Of course, you and I know that there is far more to reduction of cardiovascular risk applied to a framework of serial plaque quantification ("tracking plaque"!) than statin drugs. I doubt that a man as intelligent as Dr. Grundy truly believes this. I suspect that he is simply stating what he knows what will be published without resistance in the standard medical literature, trying to achieve a modest incremental success just by raising consciousness about heart scanning and plaque imaging: first things first.

Maybe next will be a plaque-tracking, or even a plaque-reducing, mainstream conversation, just like the one we've been conducting for the past four years.

Track Your Plaque success story blows it

Joe was a Track Your Plaque Success Story. With a starting heart scan score of 278, he dropped it 12 months later to 264, a 5% reduction. Though not a huge reduction, Joe's risk for a heart attack or other coronary event was virtually zero. I was very proud of Joe.

Among the culprit lipoprotein patterns that caused Joe's plaque was lipoprotein(a), or Lp(a). Niacin was therefore crucial to his program. It was among the principal reasons he dropped his heart scan score and reduced his risk for heart attack so dramatically.

Since he retired, Joe has been freewheeling around the country, traveling and having a great time. He consequently stopped thinking about his heart disease and Lp(a). He also tired of the occasional hot flushes he'd experienced with niacin. Though the flushes were promptly aborted by drinking two glasses of water, he simply didn't want to be bothered.

So when Joe saw this interesting and tantalizing "flush-free niacin" on the store shelf, he grabbed it.

Joe came back to the office. His blood pressure was 190/94, so high that he was having occasional chest pains from it (which can happen when something called "left ventricular diastolic dysfunction" develops from hypertension). His lipoprotein patterns were terrible, including a big upward jump in Lp(a) and drop in HDL. So I asked him to have another heart scan right away: Score 371, a 40% increase. In other words, his program went down the toilet.

Why?

Simple: Flush-free niacin. I've said it before (No flush = No effect and No flush niacin kills) and I'll say it again:

Flush-free or No-flush niacin is a complete, unadulterated, completely ineffective SCAM.

Flush-free or no-flush niacin is not a substitute for niacin. Joe is yet another example of how dangerous this scam can be. It turned one of our great success stories into a failure.

Please, please, please do not fall for this misleading and potentially dangerous scam product. While the product itself is not intrinsically dangerous, it denies you the benefits of the real thing: niacin.

Thankfully, the mistake in Joe's program was caught before a heart attack or other catastrophe. He did manage to pass a stress test, though with a flagrantly out-of-control blood pressure response. We'll get him back on track--but with niacin, the real thing.

Dr. Cannell comments on vitamin D lab tests

As always, Dr. John Cannell of The Vitamin D Council continues to teach us new lessons about vitamin D.

Apparently, Dr. Cannell is swamped with the attention that vitamin D is drawing, largely due to his efforts to publicize the enormous deficiency of Americans and his great talent for articulating the science. The most current newsletter, while a bit haphazard, makes some excellent new points that I reprint here.

(I did not reprint his conversation about "any form of vitamin D" being acceptable. My experience differs: In nearly 1000 patients who have taken vitamin D supplements, my experience is that most tablet forms are inconsistently absorbed, sometimes not absorbed at all. I therefore advocate only use of gelcaps or liquids. I'm told by members of Track Your Plaque, however, that they are witnessing reliable increases in blood levels of vitamin D by taking the powdered form of Bio Tech Pharmacal's product.)


Does it matter what reference lab my doctor uses?

Yes, it might make a huge difference. A number of methods exist to measure 25(OH)D in commercial labs. The two most common are mass spectrometry and a chemiluminescence method, LIAISON. The first, mass spectrometry, is highly accurate in the hands of experienced technicians given enough time to do the test properly. However, in the hands of a normally trained technician at a commercial reference lab overwhelmed with 25(OH)D tests, it may give falsely elevated readings, that is, it tells you are OK when in fact you are vitamin D deficient. The second method, chemiluminescence, LIAISON, was recently developed and is the most accurate of the screening, high throughput, methods; LabCorp uses it. Quest Diagnostics reference lab uses mass spec. Again, both Quest and LabCorp are overwhelmed by 25(OH)D requests. The problem is that the faster the technicians do the mass spec test, the more inaccurate it is likely to be. If your 25(OH)D blood test says "Quest Diagnostics" on the top, do not believe you have an adequate level (> 50 ng/ml). You may or may not; the test may be falsely elevated. Let me give you an example. A doctor at my hospital had Quest Diagnostics do a 25(OH)D. It came back as 99 ng/ml of ergocalciferol. He is not taking ergocalciferol (D2), he has never taken ergocalciferol, only cholecalciferol, and he is not taking enough to get a level of 99 ng/ml, 50 ng/ml at the most. His email to Dr. Brett Holmquist at Quest about why Quest identified a substance he was not taking went unanswered other than to say "any friend of Dr. Cannell's is a friend of ours."

Long story short: if your lab report says "LabCorp" on the top, it is probably accurate; if it says Quest Diagnostic, it may be falsely elevated. While LabCorp has also been overwhelmed with 25(OH)D requests, the LIAISON method they use is relatively easy to do and does not rely on technician skill as much as the mass spec methods do. I'm not saying this because I'm a consultant for DiaSorin, who makes LIAISON, I'm saying it because it is true. If you don't believe me, get Quest to make me an offer to be their consultant at 10 times what DiaSorin is supposed to be paying me ($10,000 per year) and see how fast I turn Quest down. If Quest fixes their test, I'd love to consult. The ironic thing: I've made both Quest and LabCorp lots of money via this newsletter, the website, and by repeatedly telling the press that people need to know their 25(OH)D level, which has contributed to the skyrocketing sales of 25(OH)D blood tests.

Demand for vitamin D tests soars as nutrient's potential benefits touted.

Here you can help. Find out which labs in your town use Quest Diagnostics and which use LabCorp. Have a 25(OH)D test at both labs the same day (you will have to pay for them yourself). Then send both results to the Vitamin D Council address below. If Quest Diagnostics does not fix their 25(OH)D test, the Vitamin D Council will fix it for them.



My doctor prescribed Drisdol, 50,000 IU per week. What is it?

Drisdol is a prescription of 50,000 IU tablets of ergocalciferol or D2. Ergocalciferol is not vitamin D but it is similar. It is made by irradiating ergosterol, which is found in many living things, such as yeast. D2 is not normally found in humans and most studies show it does not raise 25(OH)D levels as well as human vitamin D (cholecalciferol or D3) does. However, Drisdol is a lot better than nothing. The best thing to do, if you are vitamin D deficient, and a human, is to take human vitamin D, cholecalciferol, A.K.A. vitamin D3.



What is the ideal level of 25(OH)D?

We don't know. However, thanks to Bruce Hollis, Robert Heaney, Neil Binkley, and others, we now know the minimal acceptable level. It is 50 ng/ml. In a recent study, Heaney et al enlarged on Bruce Hollis's seminal work by analyzing five studies in which both the parent compound, cholecalciferol, and 25(OH)D levels were measured. It turn out that the body does not reliably begin storing the parent compound (cholecalciferol) in fat and muscle tissue until 25(OH)D levels get above 50 ng/ml. The average person starts to store cholecalciferol at 40 ng/ml, but at 50 ng/ml, virtually everyone begins to store it for future use. That is, at levels below 50 ng/ml, the body is usually using up the vitamin D as fast as you make it or take it, indicating chronic substrate starvation, not a good thing.

Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):631-4.

Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008 Jun;87(6):1738-42.



I have advanced renal failure and I'm on dialysis, how much vitamin D should I take?

The same as everyone else. Since I have told you about commercial labs ripping you off, let's add some drug companies. Patients with advanced renal failure need activated vitamin D or one of it's analogs, available by prescription. This is very important as their kidneys cannot make enough 1,25-dihydroxy-vitamin D (calcitriol) to maintain serum calcium. However, the rest of their tissues activate vitamin D just fine and when those tissues get enough, and when the kidneys get more vitamin D, the calcitriol spills out into the blood, lowering their need for prescription calcitriol or one of its analogs. The companies that make the analogs don't like that, it means reduced sales. So these companies do nothing, the scientists behind these companies say nothing, and renal failure patients die prematurely from one of the vitamin D deficiency diseases.

Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007 Dec;22 Suppl 2:V64-8.



When I asked my doctor for a 25(OH)D blood test, he just laughed and said it was all idiotic. What can I do?

Help me unleash the dogs of war, the plaintiff attorneys. If you read about past nutritional epidemics caused by society, such as beriberi or pellagra, you will realize that education alone will take decades. Physicians successfully fought against the idea that thiamine deficiency caused beriberi for decades. However, things are different now. The agents of change in modern America, as obnoxious as they are, are plaintiff attorneys. Once the first malpractice lawsuits claiming undiagnosed and untreated vitamin D deficiency led to breast cancer, autism, heart disease, etc., get past summary judgment, and they will, and end up in front of a jury, and they will, things will change rapidly. One of the main reason physicians do what they do is fear of lawsuits. In a matter of months, arrogance and ignorance will give way to 25(OH)D tests and vitamin D supplementation.

Goodwin JS, Tangum MR. Battling quackery: attitudes about micronutrient supplements in American academic medicine. Arch Intern Med. 1998 Nov 9;158(20):2187-91.


And, to help support Dr. Cannell's efforts (I sent him a check for $250 a few months back; time for more), here is his contact info:

John Cannell, MD
The Vitamin D Council

Send your tax-deductible contributions to:

The Vitamin D Council
9100 San Gregorio Road
Atascadero, CA 93422

Privileged information

In 1910, taking a person's blood pressure was considered revolutionary, a high-tech practice that was of uncertain benefit.

Dr. Harvey Cushing of Johns Hopkins Hospital in Baltimore had observed a blood pressure device while traveling in Europe, developed by Dr. Sciopione Riva-Rocci. Cushing brought this new technology back with him to the U.S. and promptly promoted its use, convinced that this insight into gauging the forcefulness of blood pressure would yield useful clinical insights.

But, in 1910, practicing physicians rejected this new technology, preferring to use their well-established and widely practiced technique of pulse palpation (feeling the pulse), skeptical that the new tool added value. Medical practice of the day was rich with descriptions of the strength and character of the pulse: pulsus parvus et tardus (the slow rising pulse of aortic valve stenosis), the dicrotic notch of aortic valve closure transmitted to the pulse, the "water-hammer" pulse of aortic valve insufficiency.

Over the next 20 years, however, the medical community finally gave way to the new technique, although only physicians were allowed to use blood pressure devices, as nurses were regarded as incapable of mastering the skills required to perform the procedure properly.

Stethoscopes were also gaining in popularity in the early 20th century, but were also the exclusive province of physicians trained in their use. Nurses were not allowed to use stethoscopes until the 1960s. Even then, nurses were not allowed to call them "stethoscopes," but "nurse-o-scopes" or "assistoscopes," and the nurses' version of the device was manufactured to look different to avoid confusion with the "real" doctor's tool.

And just half a century ago, if you wanted to look at a medical textbook, you would have to go to the library and ask for special permission. The librarian would lower her glasses and look you up and down to determine whether or not you were some kind of pervert. Only then might you be granted permission to peer into the pictures of organs and naked bodies.

Such has been the spirit of medicine for centuries: Medicine and its practices are meant to be secret, the insider knowledge of a privileged few.

Fast forward to 2008: The Information Age has overturned the rules of privileged information. Now you have access to the same information as I do, the same information available to practicing physicians. The playing field has been levelled.

Curiously, while information access has advanced at an instantaneous digital pace, attitudes in medicine continue to evolve at the traditional analog crawl. Many of my colleagues continue to be dismayed at the new public access to health information, belittle patients for excessive curiosity about their health, lament the erosion of their healthcare-directing authority. And while new concepts race ahead as we race towards a wiki-like collective growth in healthcare knowledge, physicians are still mired by their reluctance to abdicate their once-lofty positions as chief holders of secrets.

I believe that this is part of the reason why family doctors and cardiologists have been slow to adopt technologies like heart scans and self-empowering programs like Track Your Plaque: processes that take heart disease prevention away from the hands of physicians and place more control into the hands of the people.

Imagine the horror felt by physicians in 1935 of a young upstart nurse boldly trying to use a stethoscope to take a patient's blood pressure. You can imagine the internal horror now being felt as you and I dare to take control over heart disease and deny them the chance to put in four stents, three bypass grafts, then direct our future health habits.

But technology has a way of marching on. It will encounter resistance, bumps, and blind-alleys, but it will go on.

Dr. Jeffrey Dach on the Track Your Plaque program

Dr. Jeffrey Dach posted a great piece on his blog, Bioidentical Hormone Blog , about his perspective on the Track Your Plaque program.

It's worth reading even for those familiar with the program, just to see a slightly different perspective. He also included many great graphics to illustrate his points.

CAT Coronary Calcium Scoring, Reversing Heart Disease












Also, see Dr. Dach's Heart Disease: Part 2, for some novel thoughts.

Vitamin D and programmed aging?

As we age, we lose the capacity to activate vitamin D in the skin.

Studies suggest that, between ages 20 and 70, there is a 75% reduction in the ability to activate vitamin D. The capacity of conversion from 25 (OH) vitamin D to 1,25 di(OH) vitamin D also diminishes.

Holick M. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.



From Holick, M. 2006

This would explain why 70-year olds come to the office, just back from the Caribbean sporting dark brown tans, are still deficient, often severely, in blood levels of vitamin D (25(OH) vitamin D). A tan does not equal vitamin D.














Courtesy Ipanemic


A practical way of looking at it is that anyone 40 years old or older has lost the majority of ability for vitamin D activation.

This often makes me wonder if the loss of vitamin D activating potential is nature's way to get rid of us. After all, after 40, we've pretty much had our opportunity to recreate and make our contribution to the species (at least in a primitive world in which humans evolved): we've exhausted our reproductive usefulness to the species.

Is the programmed decline of vitamin D skin activation a way to ensure that we develop diseases of senescence (aging)? The list of potential consequences of vitamin D deficiency includes: osteoporosis, poor balance and coordination, falls and fractures; cancer of the breast, bladder, colon, prostate, and blood; reductions in HDL, increases in triglycerides; increased inflammation (C-reactive protein, CRP); declining memory and mentation; coronary heart disease.

Isn't that also pretty much a list that describes aging?

A fascinating argument in support of this idea came from study from St Thomas’ Hospital and the London School of Medicine:

Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women

Telomeres are the "tails" of DNA that were formerly thought to be mistakes, just coding for nonsense. But more recent thinking has proposed that telomeres may provide a counting mechanism that shortens with aging and accelerates with stress and illness. This study suggests that both vitamin D and inflammation (CRP) impact telomere length: the lower the vitamin D, the shorter the telomere length, particularly when inflammation is greater.
















Data supporting vitamin D's effects on preventing or treating cancer, osteoporosis, lipid abnormalities, inflammation, cardiovascular disease, etc., is developing rapidly.

Now the big question: If declining vitamin D is nature's way of ensuring our decline and death, does maintaining higher vitamin D also maintain youthfulness?

I don't have an answer, but it's a really intriguing idea.